Increase in cellular glutamate levels stimulates exocytosis in pancreatic β-cells  by Høy, Marianne et al.
Increase in cellular glutamate levels stimulates exocytosis in
pancreatic L-cells
Marianne Hya, Pierre Maechlerb, Alexander M. Efanova;1, Claes B. Wollheimb,
Per-Olof Berggrenc, Jesper Gromadaa;
aIslet Discovery Research, Novo Nordisk A/S, Novo Alle, 2880 Bagsvaerd, Denmark
bDivision of Clinical Biochemistry, Department of Internal Medicine, University Medical Center, Geneva, Switzerland
cThe Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institutet, Karolinska Hospital L3,
171 76 Stockholm, Sweden
Received 14 August 2002; accepted 24 September 2002
First published online 7 October 2002
Edited by Jacques Hanoune
Abstract Glutamate has been implicated as an intracellular
messenger in the regulation of insulin secretion in response to
glucose. Here we demonstrate by measurements of cell capaci-
tance in rat pancreatic L-cells that glutamate (1 mM) enhanced
Ca2+-dependent exocytosis. Glutamate (1 mM) also stimulated
insulin secretion from permeabilized rat L-cells. The e¡ect was
dose-dependent (half-maximum at 5.1 mM) and maximal at 10
mM glutamate. Glutamate-induced exocytosis was stronger in
rat L-cells and clonal INS-1E cells compared to L-cells isolated
from mice and in parental INS-1 cells, which correlated with the
expressed levels of glutamate dehydrogenase. Glutamate-in-
duced exocytosis was inhibited by the protonophores FCCP
and SF6847, by the vacuolar-type H+-ATPase inhibitor ba¢lo-
mycin A1 and by the glutamate transport inhibitor Evans Blue.
Our data provide evidence that exocytosis in L-cells can be
modulated by physiological increases in cellular glutamate lev-
els. The results suggest that stimulation of exocytosis is asso-
ciated with accumulation of glutamate in the secretory granules,
a process that is dependent on the transgranular proton gra-
dient.
6 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In addition to closing the ATP-regulated Kþ-channels, glu-
cose also promotes insulin secretion under conditions of
clamped cytoplasmic-free Ca2þ concentration ([Ca2þ]i) [1].
This secretory response requires one or several additive mes-
sengers that are distinct from ATP and generated by mito-
chondrial metabolism. A putative factor was recently identi-
¢ed as glutamate [2]. In the pancreatic L-cell, glutamate can be
formed in the mitochondria from K-ketoglutarate, a tricarbox-
ylic-acid (TCA) cycle intermediate, by glutamate dehydroge-
nase (GDH). Stimulation of insulin secretion by glutamate is
glucose-dependent since the amino acid is produced from glu-
cose [3]. In addition, glutamate does not initiate insulin secre-
tion but potentiates secretion induced by a rise in [Ca2þ]i [2].
The increase in glutamate levels occurs 5^10 min after cell
stimulation with glucose [2] and coincides with the second
sustained phase of the biphasic glucose-induced insulin secre-
tion [4].
In the present study, we have measured the exocytotic re-
sponse to glutamate in primary rat and mouse L-cells and
INS-1 insulinoma cells. We provide evidence that the gluta-
mate uptake mechanism in the insulin-containing granules is
related to the mechanisms initially reported for synaptic
vesicles and depends on the transgranular Hþ gradient.
2. Materials and methods
2.1. Isolation and culture of cells
Islets were isolated from male Wistar rats (200^250 g) by collage-
nase digestion of excised pancreata. The animals were obtained from
Bomholtgaﬁrd (Ry, Denmark) or in-house breeding (CMU-Zootechnie,
Geneva, Switzerland). Mouse islets were obtained from female NMRI
mice (22^25 g; Bomholtgaﬁrd). The islets were dispersed into single
cells by shaking in a Ca2þ-free medium. The cells were cultured in a
humidi¢ed atmosphere with 5% CO2 for up to 3 days in RPMI-1640
medium (Gibco BRL, Life Technologies, UK) supplemented with
10% heat-inactivated fetal calf serum, 100 i.u./ml penicillin and 100
Wg streptomycin. Parental INS-1 and INS-1E cells, cloned from the
parental INS-1 cell line [5], were cultured as described in [2].
2.2. Electrophysiology
Exocytosis was monitored as increases in cell membrane capaci-
tance using the standard whole-cell con¢guration, an EPC-9 patch-
clamp ampli¢er (HEKA Elektronik, Lamprecht/Pfalz, Germany) and
the Pulse software (version 8.01; HEKA Elektronik). The interval
between two successive points was 0.2 s and the measurements of
cell capacitance were initiated 6 5 s following establishment of the
whole-cell con¢guration. The extracellular medium consisted of (in
mM) 138 NaCl, 5.6 KCl, 2.6 CaCl2, 1.2 MgCl2, 5 HEPES (pH 7.4
with NaOH) and 5 D-glucose. The electrode solution consisted of (in
mM) 135 KCl, 10 NaCl, 1 MgCl2, 5 HEPES, 3 Mg-ATP, 10 EGTA
(ethylene glycol-bis(2-aminoethyl-ether)-N,N,NP,NP-tetraacetic acid), 7
or 9 CaCl2 (pH 7.15 with KOH). In some experiments equimolar
concentrations of KCl were exchanged for potassium-L-glutamate.
The free Ca2þ concentrations of the resulting bu¡ers were 0.50 and
1.96 WM using the binding constants of Martell and Smith [6]. Ba¢-
lomycin A1 was obtained from Calbiochem (La Jolla, CA, USA). All
other chemicals were purchased from Sigma.
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2.3. Insulin secretion from permeabilized L-cells
Rat L-cells cultured for 2 days were permeabilized with Staphylo-
cocus K-toxin as previously described in [7], then perfused at 500 nM
free Ca2þ (in mM: 140 KCl, 5 NaCl, 7 MgSO4, 1 ATP, 20 HEPES,
10.2 EGTA, 6.67 CaCl2, pH 7.0, 0.1% bovine serum albumin) and the
e¥uent was collected. Insulin was detected by radioimmunoassay us-
ing rat insulin as standard [2].
2.4. Immunoblotting
Western blot analysis was performed as described previously [4].
2.5. Statistical analysis
Results are presented as mean valuesR S.E.M. for indicated num-
bers of experiments. The exocytotic rate is presented as increases in
cell capacitance during the ¢rst 60 s following establishment of the
whole-cell con¢guration, excluding any rapid changes during the ini-
tial 10 s required for equilibration of the pipette solution with cytosol.
Statistical signi¢cance was evaluated using Student’s t-test (Figs. 1
and 3) or Dunnett’s test for multiple comparisons (Fig. 2A^D).
3. Results
Exocytosis was elicited by intracellular dialysis with a Ca2þ-
EGTA bu¡er with a free Ca2þ concentration of 500 nM
through the recording pipette. Inclusion of 1 mM glutamate
in the pipette solution stimulated exocytosis (Fig. 1A). On
average (Fig. 1B), glutamate accelerated exocytosis by 43%
(P6 0.05; n=5) when measured over the ¢rst 60 s after es-
tablishment of the whole-cell con¢guration. This is consistent
with the observation that insulin secretion was stimulated by
1 mM glutamate in permeabilized rat L-cells perfused with
1 mM ATP and 500 nM free Ca2þ (Fig. 1C).
The e¡ect of glutamate on exocytosis was dose-dependent
(Fig. 2A, insert). In this series of experiments exocytosis was
elicited by infusion of a maximal [Ca2þ]i of 2 WM. Exocytosis
was stimulated already at 1 mM glutamate and maximal en-
hancement of secretion was observed at 10 mM (Fig. 2A).
Half-maximal stimulation was observed at 5.1 mM glutamate.
The observed e¡ects are speci¢c for L-glutamate as D-gluta-
mate (10 mM) did not produce signi¢cant changes of exocy-
tosis and L- and D-aspartate (10 mM) were inactive (data not
shown).
It has previously been reported that the expression of GDH
is lower in mouse than in rat islets. This is paralleled by a
clear biphasic glucose-induced insulin secretion in the perfused
rat pancreas, whereas in the mouse glucose essentially elicits
transient monophasic insulin release [4]. Interestingly, the ef-
fect of glutamate on high (2 WM) Ca2þ-induced exocytosis was
stronger in rat than mouse L-cells (Fig. 2A,B). In mouse
L-cells, a maximal glutamate concentration of 10 mM only
stimulated exocytosis by 35%. This should be compared to
56% stimulation in rat L-cells (Fig. 2A). This results mainly
from a lower rate of exocytosis in the absence of glutamate in
rat L-cells (11.0 R 0.4 fF/s; n=5) compared to mouse L-cells
(13.4 R 1.5 fF/s; n=10), whereas the maximal secretion rates
were similar. Half-maximal stimulation was observed at 5.9
mM glutamate in mouse L-cells.
Glutamate (10 mM) also elicited a more pronounced stim-
ulation of exocytosis in clonal INS-1E cells (84% stimulation)
as compared to parental INS-1 cells (34% enhancement; Fig.
2C,D). Again, this di¡erence mainly re£ects a lower rate of
exocytosis in the absence of glutamate in INS-1E cells. Half-
maximal stimulation was observed at 2.4 mM glutamate in
INS-1E cells and 3.3 mM in parental INS-1 cells, respectively.
Interestingly, the stronger stimulation of exocytosis by gluta-
mate in INS-1E cells was associated with a 34% (P6 0.005;
n=3) higher expression of GDH as revealed by quantitative
immunoblotting analysis (parental INS-1 cells: 0.40R 0.09 ng
GDH/Wg total cellular protein vs. 0.54R 0.08 ng GDH/Wg to-
tal cellular protein in INS-1E cells ; Fig. 2E).
How might glutamate promote exocytosis? The insulin-con-
taining granules are acidic inside. This pH gradient is gener-
ated by a vacuolar-type Hþ-ATPase and is believed to drive
glutamate uptake into the granules via an as yet unidenti¢ed
transporter. This is consistent with the ¢nding that dissipation
of the proton gradient by the protonophore FCCP (carbonyl
cyanide p-tri£uoromethoxyphenylhydrazone; 0.1 WM) inhib-
ited glutamate (10 mM)-induced exocytosis in rat L-cells
(Fig. 3A,B). FCCP also reduced basal secretion by 44%. Oli-
gomycin (1 Wg/ml) did not a¡ect basal and glutamate-evoked
exocytosis (Fig. 3A,B), suggesting that inhibition of exocytosis
observed in the presence of FCCP does not interfere with
mitochondria function. A similar inhibition of glutamate-in-
duced exocytosis was observed in the presence of the proto-
nophore SF6847 (3,5-di-tert-butyl-4-hxdroxybenzylidenerma-
lononitrile ; 0.5 WM). It is important to emphasize that all
experiments were performed in the presence of 3 mM Mg-
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Fig. 1. Glutamate stimulates insulin exocytosis in rat pancreatic
L-cells. A: Increases in cell capacitance observed during the ¢rst
2 min after establishment of the standard whole-cell con¢guration
elicited by intracellular infusion with a Ca2þ-EGTA bu¡er with a
free Ca2þ concentration of 500 nM in the absence (Control) or pres-
ence of 1 mM L-glutamate in the pipette solution. Throughout the
recording, the cell was clamped at 370 mV in order to avoid activa-
tion of the voltage-dependent Ca2þ-channels that would otherwise
interfere with the capacitance measurements. B: Histogram depict-
ing mean rates of increase in cell capacitance (vCm/vt) in the ab-
sence and presence of 1 mM glutamate during the ¢rst 60 s after es-
tablishment of the whole-cell con¢guration. Data are mean values
of ¢ve individual experiments under both conditions. *P6 0.05 vs.
control. C: E¡ect of L-glutamate (1 mM) on insulin secretion in
K-toxin permeabilized rat pancreatic islet cells. The results are
meansRS.E.M. of six individual experiments. **P6 0.01 vs. the
time point just preceding stimulation (open square).
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ATP in the pipette-¢lling solution. Accordingly, the use of
these inhibitors a¡ecting mitochondria-dependent energy me-
tabolism on intact cells would result in impaired insulin secre-
tion.
The e¡ect of glutamate on exocytosis was also abolished by
inhibition of the vacuolar-type Hþ-ATPase with ba¢lomycin
A1 (100 nM; Fig. 3C,D). In contrast, vanadate (1 mM), an
inhibitor of P-type ion-transporting ATPases, did not a¡ect
glutamate-induced exocytosis (data not shown). It has been
suggested that glutamate might stimulate insulin secretion by
inhibition of L-cell serine-threonine protein phosphatases [8].
However, this is unlikely to be the case since glutamate (10
mM) stimulated exocytosis in cells treated with the protein
phosphatase inhibitor okadaic acid (0.5 WM) to an extent
(63% stimulation) similar to that observed under control con-
ditions (56% stimulation; data not shown). These data suggest
that the abrogation of glutamate-induced exocytosis observed
with FCCP, SF6847 and ba¢lomycin A1 is probably second-
ary to inhibition of glutamate uptake by the secretory gran-
ules. This is supported by the observation that Evans Blue (2
WM), a competitive inhibitor of the vesicular glutamate trans-
porter, abolished glutamate-induced exocytosis without a¡ect-
ing basal secretion (Fig. 3E,F). Recently, it has been convinc-
ingly demonstrated that chloride ions play an important role
in priming of insulin-containing granules. Chloride is taken up
by the granules through ClC3 chloride channels [9]. Our ¢nd-
ings extend these observations since inclusion of the chloride
channel inhibitor DIDS (100 WM) in the pipette-¢lling solu-
tion completely inhibited exocytosis in the absence of gluta-
mate but did not a¡ect glutamate-induced exocytosis (Fig.
3G,H).
4. Discussion
Glucose stimulation elicits a biphasic secretory response
consisting of an initial transient phase and a second, sustained
component. The ¢rst phase of insulin secretion is thought to
re£ect the rapid release of a readily releasable pool of gran-
 
 
Fig. 2. Dose^response relationship for glutamate-induced exocytosis in (A) rat L-cells, (B) mouse L-cells, (C) INS-1E cells and (D) parental
INS-1 cells. Increases in cell capacitance (vCm) were elicited by intracellular infusion with a Ca2þ-EGTA bu¡er with a free Ca2þ-concentration
of 2 WM. The insert in panel A shows representative traces of increases in cell capacitance with 0, 3 and 15 mM glutamate in the pipette-¢lling
solution dialyzing the cell. The lines are the best ¢t of the mean data to the Hill equation. The data are mean valuesR S.E.M. of 4^11 experi-
ments. E: Immunoblotting for GDH. Immunoblotting was performed after SDS^PAGE using 20 Wg proteins of INS-1E and parental INS-1
cell extract per lane or standard of GDH. The data are representative of three independent cell preparations. *P6 0.05; **P6 0.01 compared
to control (0 mM glutamate).
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ules. The second, slower phase re£ects the time-dependent
replenishment of this pool by priming of granules originated
from the reserve pool [10]. Glutamate has been implicated in
the control of the second sustained phase of insulin secretion
[4]. Here we extend these observations by demonstrating that
glutamate primes secretory granules and thereby accelerates
Ca2þ-dependent exocytosis in primary rat and mouse L-cells
as well as in INS-1 cells using capacitance measurements.
Glucose increases the cellular glutamate content in human
islets [2], mouse and rat islets [11] and in the rat L-cell lines
INS-1 and BRIN-D11 [2,3]. These data support the idea that
glutamate plays a role in glucose-induced insulin secretion
although this view has recently been challenged [11,12]. It is
noteworthy that these two papers are internally con£icting
since there was no change in islet glutamate levels in one
[12] and a marked increase during glucose stimulation in the
other [11]. In the latter study glutamate changes correlated
with secretory responses upon glucose stimulation, but not
in the presence of glutamine given as glutamate precursor.
Under these experimental conditions, actual cytosolic gluta-
mate levels may become saturating, as demonstrated here for
the enhancement of Ca2þ-induced exocytosis. Glutamate is
formed at elevated glucose concentrations in the mitochondria
[2,13], mainly from the TCA-cycle intermediate K-ketogluta-
rate by GDH [3]. Subsequently, glutamate is transferred to the
cytosol, where it is probably taken up by the insulin-contain-
ing granules.
Since mitochondria and possibly secretory granules contain
glutamate, measurements of glutamate in whole cells do not
yield information on changes in the cytosol, the critical com-
partment for glutamate as the putative second messenger. In
the present study we have overcome this problem by infusion
of glutamate directly to the cytosol through the recording pi-
pette. Indeed, we demonstrate that exocytosis is stimulated by
low millimolar glutamate concentrations and with a half-max-
imal stimulatory e¡ect at 2^6 mM glutamate. Interestingly,
the rates of exocytosis observed in the absence of added glu-
tamate to the cytosol in di¡erent cell types display inverse
correlation with the GDH expression levels. Cells with lower
GDH expression (parental INS-1 and mouse L-cells) exhibit
higher exocytosis rates in the absence of glutamate compared
to that in cells with higher GDH levels (INS-1E and rat L-
cells). However, inclusion of glutamate in the cytosol equal-
ized the exocytotic responses in all cell types. It is noteworthy
that GDH expression in human islets is comparable to rat
islet levels [4]. These data suggest that cell types with higher
GDH expression levels are more dependent on glutamate to
elicit their full exocytotic response, whereas in the cells with
lower GDH levels, glutamate is less important for maintaining
the high exocytosis rate.
Priming depends in part on ATP hydrolysis by the Hþ-
ATPase that electrogenically pumps protons into the granular
interior [9]. The pump will generate a large proton electro-
chemical gradient and in the absence of a counter-ion, the
large membrane potential that develops (positive inside) will
prevent further uptake of protons and thus acidi¢cation of the
granules. The activity of the pump can be used to drive the
uptake of negatively charged molecules, like glutamate, into
the secretory granules. This will allow a larger pH gradient to
develop across the granule membrane. Acidi¢cation of the
secretory granules is essential for glutamate-activated priming.
This is suggested by the present measurements of exocytosis
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Fig. 3. Glutamate-induced exocytosis depends on the transgranular
proton gradient. A: Changes in cell capacitance elicited by 2 WM
[Ca2þ]i in the presence of 10 mM glutamate (Glut), 0.1 WM FCCP
and in the combined presence of glutamate and FCCP. B: The his-
togram depicts the mean rates of cell capacitance increase (vCm/vt)
measured over the ¢rst 60 s after establishment of the whole-cell
con¢guration in the absence and presence of 10 mM glutamate, in
the presence of FCCP and in the simultaneous presence of gluta-
mate and FCCP. The histogram also depicts the average rates of ca-
pacitance increase in the presence of oligomycin (1 Wg/ml) and in
the simultaneous presence of oligomycin and glutamate. C: As in
panel A, except FCCP was replaced with 0.1 WM ba¢lomycin A1
(Ba¢l). D: Average rates of capacitance increase in the absence and
presence of ba¢lomycin A1 or SF6847 (0.5 WM) and in the simulta-
neous presence of glutamate and ba¢lomaycin A1 or SF6847. E,F:
As in panel A, except FCCP was replaced with 2 WM Evans Blue.
Mean increase in cell capacitance in the absence and presence of
glutamate and Evans Blue. G:As in panel A, except that exocytosis
was measured in the absence and presence of 10 mM glutamate and
in the absence and presence of 0.1 WM DIDS. H: Mean increase in
cell capacitance in the absence and presence of glutamate and
DIDS. The data are mean values RS.E.M. of ¢ve to seven di¡erent
cells. *P6 0.05; **P6 0.01.
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by cell capacitance and previous observations in permeabi-
lized cells [2] that dissipation of the Hþ gradient by the pro-
tonophores FCCP and SF6847 abolished the action of gluta-
mate on exocytosis. Furthermore, the inhibitor of Hþ-type
ATPase ba¢lomycin A1 prevented glutamate-induced exocy-
tosis. And ¢nally, blockade of glutamate uptake into the gran-
ules with Evans Blue abolished glutamate-evoked exocytosis.
The nature of the glutamate transporter in insulin-contain-
ing granules is unknown but it is tempting to speculate that
they have similarities with the recently identi¢ed vesicular glu-
tamate transporters VGLUT1/BNPI [14,15] and VGLUT2/
DNPI [16,17]. The present study demonstrates that glutamate
is not the only counter-ion required for priming since large
capacitance increases were recorded even in the complete ab-
sence of this mitochondrial factor. In agreement with previous
observations [9], our data suggest that the capacitance in-
crease observed in the absence of glutamate is likely to result
from chloride in£ux into the granules. Blockade of granular
ClC3 chloride channels with DIDS was shown to inhibit gran-
ular acidi¢cation and priming [9].
Glutamate accumulated inside granules is getting secreted
during stimulation of L-cell exocytosis and may serve as an
extracellular signalling molecule in a manner similar to that in
the central nervous system. Ionotropic and metabotropic glu-
tamate receptors have been identi¢ed on the plasma mem-
brane in all islet cell types [18]. Thus, glutamate may act
both in autocrine and paracrine manners in the complex reg-
ulation of hormone release from the di¡erent cell types within
an islet. Interestingly, it has recently been reported that KTC6
glucagonoma cells accumulate glutamate in their secretory
granules similar to that reported in the present study and
secrete glutamate through exocytosis, the mechanism resem-
bling that in neurons and pinealocytes [19].
In conclusion, our data suggest that glutamate at physio-
logical levels primes L-cell secretory granules for release. This
process is dependent on glutamate uptake into the granules, a
process fuelled by a proton electrochemical gradient across
the secretory granule membrane. Finally, the rate of gluta-
mate-stimulated exocytosis correlates with the expression lev-
els of GDH, with the highest level observed in rat L-cells and
INS-1E cells. This suggests that INS-1E cells may provide a
good model to explore further the mechanism by which glu-
tamate primes granules and its relationship to the GDH ex-
pression level.
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